Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
Annual Report 2018
We published our Annual Report 2018 on 12 March 2019. View the summary and download the full report or individual sections.
Latest information
Latest press releases
- GSK announces further positive data from DREAMM-1 study of anti-BCMA antibody-drug conjugate in patients with relapsed/refractory multiple myeloma
- Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer
- ViiV Healthcare presents positive, 48-week data from two pivotal phase III studies showing long-acting, injectable two-drug regimen of cabotegravir and rilpivirine has similar efficacy to daily, three-drug oral treatment in adults living with HIV-1 infection
2018 Full year and fourth quarter results announcement
We announced our full year and fourth quarter results for the period ended 31 December 2018 on Wednesday 06 February.